Evidence map›Paper›PMID 22415309›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2012

Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesis.

Mitsuteru Natsuizaka, Seiji Naganuma, Shingo Kagawa, Shinya Ohashi, Azal Ahmadi, Harry Subramanian, Sanders Chang, Kei J Nakagawa, Xinjun Ji, Stephen A Liebhaber and 2 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Mitsuteru NatsuizakaGastroenterology Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-2144, USA.
Seiji Naganuma
Shingo Kagawa
Shinya Ohashi
Azal Ahmadi
Harry Subramanian
Sanders Chang
Kei J Nakagawa
Xinjun Ji
Stephen A Liebhaber
Andres J Klein-Szanto
Hiroshi Nakagawa
University of Pennsylvania · USFox Chase Cancer Center · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2003 to 2023
$31.7M
Alpha-Globin expression: Post transcriptional mechanismsR37HL065449 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LIEBHABER, STEPHEN AARON · 2004 to 2013
$3.9M
The molecular regulation of IGFBP-3 in esophageal epthelial cellsR01DK077005 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2007 to 2011
$1.3M
NCI NIH HHS P01 CA098101NCI NIH HHS P01CA098101NCI NIH HHS P30 CA016520NHLBI NIH HHS R37 HL065449NHLBI NIH HHS R37-HL65449NIDDK NIH HHS P30 DK050306NIDDK NIH HHS P30-DK050306NIDDK NIH HHS R01 DK077005NIDDK NIH HHS R01DK077005
6 · The paper itself

Abstract

Insulin-like growth factor binding protein (IGFBP)-3 regulates cell proliferation and apoptosis in esophageal squamous cell carcinoma (ESCC) cells. We have investigated how the hypoxic tumor microenvironment in ESCC fosters the induction of IGFBP3. RNA interference experiments revealed that hypoxia-inducible factor (HIF)-1α, but not HIF-2α, regulates IGFBP3 mRNA induction. By chromatin immunoprecipitation and transfection assays, HIF-1α was found to transactivate IGFBP3 through a novel hypoxia responsive element (HRE) located at 57 kb upstream from the transcription start site. Metabolic labeling experiments demonstrated hypoxia-mediated inhibition of global protein synthesis. 7-Methyl GTP-cap binding assays suggested that hypoxia suppresses cap-dependent translation. Experiments using pharmacological inhibitors for mammalian target of rapamycin (mTOR) suggested that a relatively weak mTOR activity may be sufficient for cap-dependent translation of IGFBP3 under hypoxic conditions. Bicistronic RNA reporter transfection assays did not validate the possibility of an internal ribosome entry site as a potential mechanism for cap-independent translation for IGFBP3 mRNA. Finally, IGFBP3 mRNA was found enriched to the polysomes. In aggregate, our study establishes IGFBP3 as a direct HIF-1α target gene and that polysome enrichment of IGFBP3 mRNA may permit continuous translation under hypoxic conditions.

Indexed as

Protein BiosynthesisAnimalsCarcinoma, Squamous CellCell Line, TumorEsophageal NeoplasmsHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitInsulin-Like Growth Factor Binding Protein 3MiceNeoplasm TransplantationPolyribosomesRNA Cap AnalogsRNA CapsRNA, MessengerTOR Serine-Threonine Kinases7-methylguanosine triphosphateHypoxia-Inducible Factor 1, alpha SubunitInsulin-Like Growth Factor Binding Protein 3MTOR protein, humanRNA Cap AnalogsRNA CapsRNA, MessengerTOR Serine-Threonine Kinases

Identifiers

PMID22415309
PMCPMC3360153
OpenAlexW2112249893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.